APA (7th ed.) Citation

SAM, U., F, M., S, S. A., F, P., A, G., R, M., . . . A, C. (2024). The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population. Cancers, 16(19), . https://doi.org/10.3390/cancers16193419

Chicago Style (17th ed.) Citation

SAM, Urru, et al. "The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population." Cancers 16, no. 19 (2024). https://doi.org/10.3390/cancers16193419.

MLA (9th ed.) Citation

SAM, Urru, et al. "The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population." Cancers, vol. 16, no. 19, 2024, https://doi.org/10.3390/cancers16193419.